AR013240A1 - Composiciones, equipos y metodos para inhibir los deseordenes neurovasculares cerebrales y los dolores de cabeza musculares - Google Patents
Composiciones, equipos y metodos para inhibir los deseordenes neurovasculares cerebrales y los dolores de cabeza muscularesInfo
- Publication number
- AR013240A1 AR013240A1 ARP980103565A ARP980103565A AR013240A1 AR 013240 A1 AR013240 A1 AR 013240A1 AR P980103565 A ARP980103565 A AR P980103565A AR P980103565 A ARP980103565 A AR P980103565A AR 013240 A1 AR013240 A1 AR 013240A1
- Authority
- AR
- Argentina
- Prior art keywords
- local anesthetic
- headaches
- neurovascular
- composition
- compositions
- Prior art date
Links
- 206010019233 Headaches Diseases 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 5
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 210000003205 muscle Anatomy 0.000 title abstract 2
- 208000014644 Brain disease Diseases 0.000 title 1
- 239000003589 local anesthetic agent Substances 0.000 abstract 5
- 231100000869 headache Toxicity 0.000 abstract 4
- 239000004615 ingredient Substances 0.000 abstract 3
- 208000017376 neurovascular disease Diseases 0.000 abstract 2
- 208000018152 Cerebral disease Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 206010043269 Tension headache Diseases 0.000 abstract 1
- 208000008548 Tension-Type Headache Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 230000004118 muscle contraction Effects 0.000 abstract 1
- 230000003387 muscular Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000306 recurrent effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Otolaryngology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89719297A | 1997-07-21 | 1997-07-21 | |
| US7284598P | 1998-01-28 | 1998-01-28 | |
| US8455998P | 1998-05-06 | 1998-05-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR013240A1 true AR013240A1 (es) | 2000-12-13 |
Family
ID=27372174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980103565A AR013240A1 (es) | 1997-07-21 | 1998-07-21 | Composiciones, equipos y metodos para inhibir los deseordenes neurovasculares cerebrales y los dolores de cabeza musculares |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0999839B1 (https=) |
| JP (1) | JP4521117B2 (https=) |
| KR (1) | KR20010022041A (https=) |
| CN (1) | CN1267219A (https=) |
| AR (1) | AR013240A1 (https=) |
| AT (1) | ATE269702T1 (https=) |
| AU (1) | AU8574398A (https=) |
| BR (1) | BR9810773A (https=) |
| CA (1) | CA2297097C (https=) |
| DE (1) | DE69824730T2 (https=) |
| EE (1) | EE200000050A (https=) |
| HU (1) | HUP0003953A3 (https=) |
| ID (1) | ID24903A (https=) |
| IL (2) | IL134087A0 (https=) |
| IS (1) | IS5349A (https=) |
| NO (1) | NO20000293L (https=) |
| PL (1) | PL338176A1 (https=) |
| SK (1) | SK187899A3 (https=) |
| TR (1) | TR200000149T2 (https=) |
| WO (1) | WO1999003473A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704349D0 (en) * | 1997-03-03 | 1997-04-23 | Chiroscience Ltd | Levobupivacaine and its use |
| JP4632499B2 (ja) * | 1999-08-26 | 2011-02-16 | 武田薬品工業株式会社 | 鼻粘膜付着マトリックス |
| AU2100901A (en) * | 1999-12-15 | 2001-06-25 | Bruce H. Levin | Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation |
| GB9930083D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
| US7117033B2 (en) | 2000-05-08 | 2006-10-03 | Brainsgate, Ltd. | Stimulation for acute conditions |
| AU5662001A (en) | 2000-05-08 | 2001-11-20 | Brainsgate Ltd. | Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the bbb and cerebral blood flow |
| US7640062B2 (en) | 2000-05-08 | 2009-12-29 | Brainsgate Ltd. | Methods and systems for management of alzheimer's disease |
| US7146209B2 (en) | 2000-05-08 | 2006-12-05 | Brainsgate, Ltd. | Stimulation for treating eye pathologies |
| US6853858B2 (en) | 2000-05-08 | 2005-02-08 | Brainsgate, Ltd. | Administration of anti-inflammatory drugs into the central nervous system |
| WO2004043218A2 (en) | 2002-11-14 | 2004-05-27 | Brainsgate Ltd. | Surgical tools and techniques for stimulation |
| US7561919B2 (en) | 2002-11-14 | 2009-07-14 | Brainsgate Ltd. | SPG stimulation via the greater palatine canal |
| WO2005062829A2 (en) | 2003-12-19 | 2005-07-14 | Advanced Bionics Corporation | Skull-mounted electrical stimulation system and method for treating patients |
| US8010189B2 (en) | 2004-02-20 | 2011-08-30 | Brainsgate Ltd. | SPG stimulation for treating complications of subarachnoid hemorrhage |
| US9233245B2 (en) | 2004-02-20 | 2016-01-12 | Brainsgate Ltd. | SPG stimulation |
| US8055347B2 (en) | 2005-08-19 | 2011-11-08 | Brainsgate Ltd. | Stimulation for treating brain events and other conditions |
| US7592371B2 (en) | 2004-08-18 | 2009-09-22 | Medrx Co., Ltd. | External preparation |
| AU2009274137B2 (en) * | 2008-07-21 | 2013-10-31 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| DE102008037682A1 (de) | 2008-08-14 | 2010-04-08 | Strackharn, Klaus, Dr.med. | Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen |
| US9889109B2 (en) | 2012-09-28 | 2018-02-13 | St. Renatus, Llc | Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines |
| CN103432378A (zh) * | 2013-08-15 | 2013-12-11 | 吕清华 | 一种治疗神经血管性头痛的中药 |
| US9675796B2 (en) | 2013-11-10 | 2017-06-13 | Brainsgate Ltd. | Implant and delivery system for neural stimulator |
| US10271907B2 (en) | 2015-05-13 | 2019-04-30 | Brainsgate Ltd. | Implant and delivery system for neural stimulator |
| CN113573705A (zh) * | 2018-12-19 | 2021-10-29 | 诺迪克控股公司 | 鼻内利多卡因的治疗组合物 |
| WO2020152212A1 (en) * | 2019-01-22 | 2020-07-30 | Icm (Institut Du Cerveau Et De La Moelle Épinière) | Local anesthetic for the treatment of neurological symptoms resulting from brain dysfunctions |
| GB2628149A (en) * | 2023-03-16 | 2024-09-18 | Lee Nathaniel Wurie | Nasal spray for performing sphenopalatine ganglion block |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321061D0 (en) * | 1993-10-13 | 1993-12-01 | Chiroscience Ltd | Analgestic agent and its use |
| DE19524691A1 (de) * | 1995-07-06 | 1997-01-09 | Liedtke Pharmed Gmbh | Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen |
| DE19526019A1 (de) * | 1995-07-17 | 1997-01-23 | Liedtke Pharmed Gmbh | Methode und Zusammensetzung einer topischen Therapie von Kopfschmerzen |
| BE1009851A3 (fr) * | 1996-01-11 | 1997-10-07 | Thiebauld Charles Marie | Composition pharmaceutique pour le traitement des cephalees et son utilisation. |
| GB2315673A (en) * | 1996-08-01 | 1998-02-11 | Merck & Co Inc | Treatment of migraine |
| US5891885A (en) * | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
| GB9704349D0 (en) * | 1997-03-03 | 1997-04-23 | Chiroscience Ltd | Levobupivacaine and its use |
-
1998
- 1998-07-17 CN CN98808214A patent/CN1267219A/zh active Pending
- 1998-07-17 EP EP98936893A patent/EP0999839B1/en not_active Expired - Lifetime
- 1998-07-17 HU HU0003953A patent/HUP0003953A3/hu unknown
- 1998-07-17 IL IL13408798A patent/IL134087A0/xx active IP Right Grant
- 1998-07-17 AT AT98936893T patent/ATE269702T1/de not_active IP Right Cessation
- 1998-07-17 AU AU85743/98A patent/AU8574398A/en not_active Abandoned
- 1998-07-17 KR KR1020007000610A patent/KR20010022041A/ko not_active Withdrawn
- 1998-07-17 PL PL98338176A patent/PL338176A1/xx unknown
- 1998-07-17 DE DE69824730T patent/DE69824730T2/de not_active Expired - Lifetime
- 1998-07-17 TR TR2000/00149T patent/TR200000149T2/xx unknown
- 1998-07-17 JP JP2000502772A patent/JP4521117B2/ja not_active Expired - Fee Related
- 1998-07-17 WO PCT/US1998/014870 patent/WO1999003473A1/en not_active Ceased
- 1998-07-17 EE EEP200000050A patent/EE200000050A/xx unknown
- 1998-07-17 BR BR9810773-9A patent/BR9810773A/pt not_active IP Right Cessation
- 1998-07-17 CA CA002297097A patent/CA2297097C/en not_active Expired - Lifetime
- 1998-07-17 ID IDW20000123D patent/ID24903A/id unknown
- 1998-07-17 SK SK1878-99A patent/SK187899A3/sk unknown
- 1998-07-21 AR ARP980103565A patent/AR013240A1/es unknown
-
2000
- 2000-01-17 IL IL134087A patent/IL134087A/en not_active IP Right Cessation
- 2000-01-18 IS IS5349A patent/IS5349A/is unknown
- 2000-01-20 NO NO20000293A patent/NO20000293L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU8574398A (en) | 1999-02-10 |
| HUP0003953A3 (en) | 2002-02-28 |
| ID24903A (id) | 2000-08-31 |
| DE69824730D1 (de) | 2004-07-29 |
| BR9810773A (pt) | 2000-09-19 |
| CA2297097C (en) | 2009-04-07 |
| KR20010022041A (ko) | 2001-03-15 |
| PL338176A1 (en) | 2000-10-09 |
| DE69824730T2 (de) | 2005-07-14 |
| NO20000293L (no) | 2000-03-20 |
| TR200000149T2 (tr) | 2000-05-22 |
| IL134087A (en) | 2006-10-31 |
| CA2297097A1 (en) | 1999-01-28 |
| EE200000050A (et) | 2000-10-16 |
| EP0999839B1 (en) | 2004-06-23 |
| EP0999839A1 (en) | 2000-05-17 |
| JP4521117B2 (ja) | 2010-08-11 |
| CN1267219A (zh) | 2000-09-20 |
| HUP0003953A1 (hu) | 2002-01-28 |
| NO20000293D0 (no) | 2000-01-20 |
| JP2001513483A (ja) | 2001-09-04 |
| SK187899A3 (en) | 2000-12-11 |
| IS5349A (is) | 2000-01-18 |
| WO1999003473A1 (en) | 1999-01-28 |
| ATE269702T1 (de) | 2004-07-15 |
| IL134087A0 (en) | 2001-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR013240A1 (es) | Composiciones, equipos y metodos para inhibir los deseordenes neurovasculares cerebrales y los dolores de cabeza musculares | |
| US6432986B2 (en) | Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches | |
| JP6200648B2 (ja) | 三叉神経・自律神経性頭痛、片頭痛、および血管症状の治療および予防のための組成物 | |
| PA8515001A1 (es) | Una composicion farmaceutica para el tratamiento del dolor agudo, cronico y/o el dolor neuropatico y las migrañas | |
| BR0112661A (pt) | Nova combinação de agonista (5ht2) e antagonista (5ht6) da serotonina como formulação farmacêutica | |
| ES2295609T3 (es) | Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor. | |
| AU645023B2 (en) | Compositions and method for treating painful, inflammatory or allergic disorders | |
| CU23226B7 (es) | COMPOSICIONES ANALGéSICAS QUE COMPRENDEN COMPUESTOS ANTI-EPILéPTICOS Y ANTINFLAMATORIOS NO ESTEROIDEOS | |
| NO20050379L (no) | Anvendelse av venlafaxinhydroklorid for fremstilling av en innkapslet forlenget frigjoringsblanding | |
| KR980000447A (ko) | 미르타자핀과 하나 이상의 선택적인 세로토닌 재이용 저해제로 이루어진 약학 조성물 | |
| WO2005055921A3 (en) | Compositions for treatment of ear disorders and methods of use thereof | |
| JPH08231387A (ja) | うつ病でない雌性の哺乳動物における視床下部性無月経を処置するための医薬組成物 | |
| WO2001043733A3 (en) | Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation | |
| BR0012175A (pt) | Antagonistas de receptor de igiur5, seletivos para o tratamento de enxaqueca | |
| AR015448A1 (es) | COMBINACIoN DE UN INHIBIDOR DE REABSORCIoN DE 5-HT CON UN ANTAGONISTA O AGONISTA PARCIAL DE H5-HT1B, PROCESO PARA SU PREPARACIoN, FORMULACIoN FARMACÉUTICA QUE LA CONTIENE, SU USO PARA PREPARAR MEDICAMENTOS PARA TRATAR TRASTORNOS AFECTIVOS Y KIT QUE CONTIENE DICHA COMBINACIoN | |
| EA200001010A1 (ru) | Применение дексмедетомидина для седативного воздействия в отделении интенсивной терапии | |
| CO5190664A1 (es) | Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2 | |
| BR0111002A (pt) | Combinação de secretagogos do hormÈnio do crescimento e antidepressivos | |
| MXPA04010860A (es) | Composiciones terapeuticas de 1,2,3,6-tetrahidropirimidin-2-ona y metodos para usarla. | |
| UA37206C2 (uk) | Фармацевтична композиція, яка містить алкілсульфонамід-агоніст 5нті- подібного рецептора для ректального введення | |
| BR0005319A (pt) | Tratamento combinado para depressão e ansiedade | |
| Radev | DERMOELECTROPORATION IN THE TREATMENT OF OVERUSE INJURIES | |
| KR960040360A (ko) | 파킨슨 병의 상승작용적 치료 방법 | |
| GB9211277D0 (en) | Pharmaceutical compositions | |
| MX9704887A (es) | Composiciones farmaceuticas para el tratamiento de trastornos depresivos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |